Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 09:30 ET | Source: Ampersand Capital Partners

Ampersand Capital Partners Named to Inc.’s 2025 List of Founder-Friendly Investors for Fourth Consecutive Year

Boston, MA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Ampersand Capital Partners (“Ampersand”) has been named to Inc.’s 2025 Founder-Friendly Investors list for the fourth consecutive year. The Inc. Founder...
October 14, 2025 09:04 ET | Source: Gannet BioChem

Life Sciences Innovator Dr. Art Tipton Joins Gannet BioChem Board

Huntsville, AL, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm...
September 23, 2025 08:02 ET | Source: Julius Clinical

Julius Clinical Welcomes Bassem Saleh as Chief Executive Officer

Zeist, The Netherlands, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Julius Clinical, a leading clinical Contract Research Organization (CRO) with deep therapeutic expertise in CNS and Cardiometabolic...
January 13, 2020 06:55 ET | Source: Interpace Biosciences, Inc.

Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners

Reverse Stock Split Planned Concurrent with Closing Investment expected to support achieving cash flow break-even and accelerate Interpace’s growth plans and acquisition strategy Parsippany,...
October 17, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners

PARSIPPANY, NJ, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) announced today that it has closed on a $13 million Convertible Preferred Stock investment by Ampersand...